Why Chemed Stock Is Plummeting Today
(NYSE: CHE) -- home to hospice care provider Vitas Healthcare and Roto-Rooter -- saw its shares decline 9% as of 1 p.m. ET on Wednesday, according to data provided by S&P Global Market Intelligence.
Chemed reported second-quarter earnings that fell short of analysts' expectations, causing its share price to tumble.
While Chemed grew sales by 4% in Q2, adjusted earnings per share (EPS) declined by a staggering 22%. Meanwhile, management cut 2025 EPS guidance from $25.20 to $22.15, implying a 4% decline from last year's earnings.
Source Fool.com
Chemed Corp. Aktie
374,00 €
0,00 %
Positive Einschätzungen für Chemed Corp. überwiegen: Mehrere Buy-, keine Sell-Einschätzungen.
Für Chemed Corp. sieht die Community ein Kursziel von 546 €, was eine erhebliche Steigerung um über 20% gegenüber dem aktuellen Kurs von 374.0 € bedeutet.
